Young MR - Search Results

1

Vielma SA, Klein RL, Levingston CA, Young MR. Vielma SA, et al. Among authors: young mr. Int Immunopharmacol. 2013 Jun;16(2):224-31. doi: 10.1016/j.intimp.2013.04.002. Epub 2013 Apr 13. Int Immunopharmacol. 2013. PMID: 23587489 Free PMC article.

2

Premalignant lesions skew spleen cell responses to immune modulation by adipocytes.

Vielma SA, Klein RL, Levingston CA, Young MR. Vielma SA, et al. Among authors: young mr. Anticancer Res. 2013 May;33(5):1809-18. Anticancer Res. 2013. PMID: 23645725 Free PMC article.

3

Skewing of immune cell cytokine production by mediators from adipocytes and endothelial cells.

Vielma SA, Klein RL, Levingston CA, Young MR. Vielma SA, et al. Among authors: young mr. Adipocyte. 2014 Apr 1;3(2):126-31. doi: 10.4161/adip.28287. Epub 2014 Feb 25. Adipocyte. 2014. PMID: 24719786 Free PMC article.

4

Treatment to sustain a Th17-type phenotype to prevent skewing toward Treg and to limit premalignant lesion progression to cancer.

Young MR, Levingston CA, Johnson SD. Young MR, et al. Int J Cancer. 2016 May 15;138(10):2487-98. doi: 10.1002/ijc.29989. Epub 2016 Jan 28. Int J Cancer. 2016. PMID: 26756968 Free PMC article.

5

An exploratory approach demonstrating immune skewing and a loss of coordination among cytokines in plasma and saliva of Veterans with combat-related PTSD.

Wang Z, Mandel H, Levingston CA, Young MRI. Wang Z, et al. Hum Immunol. 2016 Aug;77(8):652-657. doi: 10.1016/j.humimm.2016.05.018. Epub 2016 May 20. Hum Immunol. 2016. PMID: 27216157 Free PMC article.

6

Premalignant Oral Lesion Cells Elicit Increased Cytokine Production and Activation of T-cells.

Johnson SD, Levingston C, Young MR. Johnson SD, et al. Among authors: young mr. Anticancer Res. 2016 Jul;36(7):3261-70. Anticancer Res. 2016. PMID: 27354582 Free PMC article.

7

Transient immunological and clinical effectiveness of treating mice bearing premalignant oral lesions with PD-1 antibodies.

Levingston CA, Young MR. Levingston CA, et al. Among authors: young mr. Int J Cancer. 2017 Apr 1;140(7):1609-1619. doi: 10.1002/ijc.30543. Epub 2017 Jan 24. Int J Cancer. 2017. PMID: 27914100 Free PMC article.

8

Cytokine and Adipokine Levels in Patients with Premalignant Oral Lesions or in Patients with Oral Cancer Who Did or Did Not Receive 1α,25-Dihydroxyvitamin D3 Treatment upon Cancer Diagnosis.

Young MR, Levingston C, Johnson SD. Young MR, et al. Cancers (Basel). 2015 Jun 25;7(3):1109-24. doi: 10.3390/cancers7030827. Cancers (Basel). 2015. PMID: 26120967 Free PMC article.

9

Local Immune Responsiveness of Mice Bearing Premalignant Oral Lesions to PD-1 Antibody Treatment.

Levingston CA, Young MRI. Levingston CA, et al. Cancers (Basel). 2017 Jun 2;9(6):62. doi: 10.3390/cancers9060062. Cancers (Basel). 2017. PMID: 28574425 Free PMC article.

10

Administration of a vaccine composed of dendritic cells pulsed with premalignant oral lesion lysate to mice bearing carcinogen-induced premalignant oral lesions stimulates a protective immune response.

De Costa AM, Justis DN, Schuyler CA, Young MR. De Costa AM, et al. Among authors: young mr. Int Immunopharmacol. 2012 Jul;13(3):322-30. doi: 10.1016/j.intimp.2012.05.004. Epub 2012 May 16. Int Immunopharmacol. 2012. PMID: 22609090 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

425 results

Search Page